MedTrace Logo

Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)

NCT04555629 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-09-21

No results posted yet for this study

Summary

This study is a feasibility randomized controlled trial (RCT) for an evidence-based intervention for people with moderate to severe dementia in Hong Kong. The psychosocial intervention is adapted from Cognitive Stimulation Therapy (CST), translated and adapted for the Hong Kong Chinese population, and developed within the Medical Research Council (MRC) framework.

Conditions

  • Dementia
  • Dementia, Vascular
  • Dementia, Mixed
  • Dementia With Lewy Bodies
  • Dementia Frontal
  • Dementia Severe
  • Dementia Moderate
  • Dementia of Alzheimer Type

Interventions

OTHER

Advanced Cognitive Stimulation Therapy Hong Kong

A modified version of Cognitive Stimulation Therapy for people with moderate to severe dementia translated and culturally adapted for the Hong Kong Chinese population.

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER

  • University College, London

    lead OTHER

Principal Investigators

  • Aimee Spector, PhD, DClinPsych · University College, London

  • Gloria Wong, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-11-01
Completion
2022-11-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04555629 on ClinicalTrials.gov